中国实用医刊
中國實用醫刊
중국실용의간
CENTRAL PLAINS MEDICAL JOURNAL
2013年
22期
26-27
,共2页
脑卒中后抑郁%黛力新
腦卒中後抑鬱%黛力新
뇌졸중후억욱%대력신
Post-stroke depression%Dailixin
目的 观察早期应用黛力新干预脑卒中后抑郁的临床疗效.方法 将120例符合诊断标准及排除标准的脑卒中后抑郁患者分为两组,常规治疗基础上,黛力新组给予口服黛力新1片/d.两组患者治疗前、治疗后2周和治疗后4周分别进行汉密织顿抑郁量表(HAMD)和神经功能抽损评分(NIHSS),评价患者的抑郁及神经功能恢复情况.结果 服用黛力新的患者抑郁状态和神经功能明显改善,与对照组相比,其治疗后2周、治疗后4周HAMD和NIHSS评分比较差异有统计学意义(P＜0.05).结论 早期应用黛力新治疗可干预脑卒中患者的抑郁状态,并促进患者神经功能恢复.
目的 觀察早期應用黛力新榦預腦卒中後抑鬱的臨床療效.方法 將120例符閤診斷標準及排除標準的腦卒中後抑鬱患者分為兩組,常規治療基礎上,黛力新組給予口服黛力新1片/d.兩組患者治療前、治療後2週和治療後4週分彆進行漢密織頓抑鬱量錶(HAMD)和神經功能抽損評分(NIHSS),評價患者的抑鬱及神經功能恢複情況.結果 服用黛力新的患者抑鬱狀態和神經功能明顯改善,與對照組相比,其治療後2週、治療後4週HAMD和NIHSS評分比較差異有統計學意義(P＜0.05).結論 早期應用黛力新治療可榦預腦卒中患者的抑鬱狀態,併促進患者神經功能恢複.
목적 관찰조기응용대력신간예뇌졸중후억욱적림상료효.방법 장120례부합진단표준급배제표준적뇌졸중후억욱환자분위량조,상규치료기출상,대력신조급여구복대력신1편/d.량조환자치료전、치료후2주화치료후4주분별진행한밀직돈억욱량표(HAMD)화신경공능추손평분(NIHSS),평개환자적억욱급신경공능회복정황.결과 복용대력신적환자억욱상태화신경공능명현개선,여대조조상비,기치료후2주、치료후4주HAMD화NIHSS평분비교차이유통계학의의(P＜0.05).결론 조기응용대력신치료가간예뇌졸중환자적억욱상태,병촉진환자신경공능회복.
Objective To observe the clinical effect of early use Dailixin for post-stroke depression.Methods One hundred and twenty patients with post-stroke depression who were according with choosing and removing conditions were randomly divided into two groups,with 60 cases in each group.The patients in treatment group were treated by Dailixin based on regular cure.Hamilton depression rating scale(HAMD) and National Institute of Health stroke scale(NIHSS) were assessed before treatment and after two weeks,four weeks treatment.Results After two weeks,four weeks treatment,depression condition and nerve function of Dailixin group improved.HAMD and NIHSS score of the treatment group was better than that of control group (P ＜ O.05).Conclusions Early use Dailixin treatment after stroke may interfere with depression conditions and can improve the nerve functional recovery of patients.
